Results 191 to 200 of about 5,569,705 (300)

The Application of Artificial Intelligence in Brucellosis: Diagnosis, Genomic Analysis, Epidemiological Prediction and Drug Discovery. [PDF]

Animals (Basel)
Liu X, Wen H, Wang T, Liu H, Xie M, Luo Y, Zuo L, Liu C, Zhou D, Wang W.   +9 more
europepmc   +1 more source

Long‐term stability of human parvovirus B19 neutralizing antibody titer trends in donor‐derived pooled plasma and plasma‐derived immunoglobulin product lots in Japan

Transfusion, EarlyView.
Abstract Background Human parvovirus B19 (B19) is a major pathogen involved in transfusion‐related infections. In Japan, B19 antigen screening is conducted during blood donation, and B19 deoxyribonucleic acid (DNA) levels in pooled plasma have remained below the limit recommended by the U.S. Food and Drug Administration (104 IU/mL).
Yugo Nishiguchi, Takamasa Inoue, Akemi Shibuya, Takahiro Sasaki, Mikihiro Yunoki, Takeru Urayama   +5 more
wiley   +1 more source

Aligning Licensure and Recommended Use to Expedite Vaccine Access in Response to the Ongoing Bundibugyo Ebolavirus Epidemic in Central Africa. [PDF]

Viruses
O'Hara GL, Halabi S.
europepmc   +1 more source

[On regulating anti-epidemic measures in pertussis and parapertussis].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1969
G N, Raĭkhshtat, A A, Sumarokov, A A, Shapiro   +2 more
openaire   +1 more source

Impact of nationwide parvovirus B19 DNA screening and identification of transfusion‐transmitted infections

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Parvovirus B19 (B19V) testing is often not required to release blood components. However, the European Pharmacopoeia requires that plasma pools for fractionation contain no more than 104 IU/mL of B19V DNA. In France, pool B19 nucleic acid testing (NAT) screening was performed by Établissement Français du Sang since ...
Virginie de la Taille, Caroline Bacquet, Marlène Guillet, Grégory Barday, Christilla Monnier, Guillaume Maccio, Pierre Gallian, Grégory Destras, Sophie Le Cam, Elodie Pouchol, Thierry Peyrard, Pierre Tiberghien, Syria Laperche   +12 more
wiley   +1 more source

Adaptive Fourier decomposition-based time-frequency analysis of COVID-19 epidemic trends and policy interventions in Washington D.C., with comparative validation in London. [PDF]

J Thorac Dis
Cen K, Li X, Lu G, Li Y, Wang Y, Zeng Z, Yang Z, Deng X, Hon C.   +8 more
europepmc   +1 more source

mTOR blockade prevents progressive proteinuria but induces hyperglycaemia in obese Dahl salt‐sensitive rats before puberty

Experimental Physiology, EarlyView.
Abstract Previous studies have demonstrated that mammalian target of rapamycin (mTOR) activity is significantly increased in the kidneys of Dahl salt‐sensitive (SS) rats during the development of renal injury. Therefore, in the present study we examined whether blockade of mTOR with rapamycin inhibits renal injury in Dahl salt‐sensitive leptin receptor
Sautan Mandal, Andrea K. Brown, Ubong S. Ekperikpe, Anukool A. Bhopatkar, Krystle M. Hughes, Tyler D. Johnson, Jonita S. Cooper, Konnor T. Wilbert, Denise C. Cornelius, Jan M. Williams   +9 more
wiley   +1 more source

Chikungunya Virus: What a Transfusion Service Needs to Know. [PDF]

Viruses
Focosi D, Sberna G, Colavita F, Maggi F, Franchini M.   +4 more
europepmc   +1 more source

Mechanistic insights into sex differences in atrial electrophysiology and arrhythmia vulnerability through sex‐specific computational models

The Journal of Physiology, EarlyView.
Abstract figure legend Sex‐specific models of the human atrial myocyte in normal sinus rhythm (nSR) and chronic atrial fibrillation (cAF) revealed increased alternans susceptibility in cAF males and DADs in females, driven primarily by ICaL and ryanodine receptor remodelling.
Nathaniel T. Herrera, Haibo Ni, Charlotte E. R. Smith, Yixuan Wu, Dobromir Dobrev, Stefano Morotti, Eleonora Grandi   +6 more
wiley   +1 more source

SARS CoV-2 seroprevalence and rising antibody titres across successive pandemic waves in accra, Ghana: August 2020 to January 2022. [PDF]

Sci Rep
Pappoe-Ashong PJ, Mingle JAA, Tetteh D, Brown CA, Nordzi SK, Mensah BT, Oliver-Commey JA, Puplampu P, Jassoy C.   +8 more
europepmc   +1 more source